One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Elsewhere in the AGA Journals
doi : 10.1016/S1542-3565(21)01234-9
Volume 20, Issue 1, January 2022, Pages A11-A12
Information for Authors and Readers
doi : 10.1016/S1542-3565(21)01235-0
Volume 20, Issue 1, January 2022, Pages A15-A16
Pseudomembranous Colitis at Colostomy Site
Kai-ChenWangKai-JyunSyu
doi : 10.1016/j.cgh.2020.09.012
Volume 20, Issue 1, January 2022, Page A17
Persistently Elevated Liver Enzymes Caused By Schistosoma mansoni
Nizar H.Senussi?VignanManne‡
doi : 10.1016/j.cgh.2020.08.050
Volume 20, Issue 1, January 2022, Page A18
Auriculate Ulcers in Gastrointestinal Tract
DaisukeMurakami?HideakiHarada?YujiAmano‡
doi : 10.1016/j.cgh.2020.09.013
Volume 20, Issue 1, January 2022, Page A19
Double-Barrel Esophagus: Deglutition at the Crossroads
Sukrit SinghSethiSanjeevSachdevaAlok KumarSingh
doi : 10.1016/j.cgh.2020.07.045
Volume 20, Issue 1, January 2022, Page e1
The Clue Is in the Stool
RitaSlim?MariaEl Gemayel?RogerNoun‡
doi : 10.1016/j.cgh.2020.07.019
Volume 20, Issue 1, January 2022, Page e2
Severe Polycystic Liver Disease With Hepatic Cyst Infection
JiahaoHu?MingyuChen?XiujunCai?†
doi : 10.1016/j.cgh.2020.07.047
Volume 20, Issue 1, January 2022, Page e3
Intramural Esophageal Dissection After Cardiopulmonary Resuscitation
GregoryPajotAnna M.Lipowska
doi : 10.1016/j.cgh.2020.07.048
Volume 20, Issue 1, January 2022, Page e4
Unusual Presentation of a Crohn’s Disease Patient: Not Your Typical Flare
AymenAlmuhaidb?JasonSina‡Chien-HuanChen?
doi : 10.1016/j.cgh.2020.08.052
Volume 20, Issue 1, January 2022, Pages e5-e6
Issue Highlights
Michael P.MannsM.D(Associate Editor)
doi : 10.1016/j.cgh.2021.10.035
Volume 20, Issue 1, January 2022, Pages 1-4
Next Generation Academic Gastroenterology
John I.Allen?‡SameerBerry‡
doi : 10.1016/j.cgh.2021.09.038
Volume 20, Issue 1, January 2022, Pages 5-8
Conceptual Model for the Hepatocellular Carcinoma Screening Continuum: Current Status and Research Agenda
Amit G.Singal?Anna S.Lok‡ZidingFeng§FasihaKanwal||aNeehar D.Parikh‡a
doi : 10.1016/j.cgh.2020.09.036
Volume 20, Issue 1, January 2022, Pages 9-18
Beyond Metoclopramide for Gastroparesis
MichaelCamilleri
doi : 10.1016/j.cgh.2021.08.052
Volume 20, Issue 1, January 2022, Pages 19-24
Towards a New Horizon for Individualized Surveillance Tools in Hepatocellular Carcinoma
So YeonKimMD, PhDYoung-SukLimMD, PhD
doi : 10.1016/j.cgh.2021.04.041
Volume 20, Issue 1, January 2022, Pages 25-27
Pain Phenotypes in Chronic Pancreatitis: Beginning to Fine-tune Our Approach to Treatment
Jonathan M.BuscagliaMDLinChangMD
doi : 10.1016/j.cgh.2020.12.032
Volume 20, Issue 1, January 2022, Pages 28-30
Serrated Polyps and the Risk of Metachronous Colorectal Advanced Neoplasia: A Systematic Review and Meta-Analysis
Yoon SukJung?Jung HoPark?Chan HyukPark‡
doi : 10.1016/j.cgh.2020.09.051
Volume 20, Issue 1, January 2022, Pages 31-43.e1
Noncontrast MRI for Hepatocellular Carcinoma Detection: A Systematic Review and Meta-analysis – A Potential Surveillance Tool?
Michael VinchillChan?‡Ya RuthHuo?‡NelsonTrieu?‡AmerMitchelle?JacobGeorge§EmilyHe||Alice UnahLee||JeffChang||JessicaYang?‡
doi : 10.1016/j.cgh.2021.02.036
Volume 20, Issue 1, January 2022, Pages 44-56.e2
Plasminogen Activator Inhibitor-1 as a Marker of Esophageal Functional Changes in Pediatric Eosinophilic Esophagitis
PreranaWilliamson?‡§JamesProudfoot?ArmenGharibans§¶#LucasDohil???RobertNewbury?§‡‡JacquelineBarsamian§MaheenHassan?‡§ReneeRawson???DavidKatzka§§??RichardKurten¶¶RanjanDohil?‡§HayatMousa?‡§SeemaAceves§??##
doi : 10.1016/j.cgh.2020.09.040
Volume 20, Issue 1, January 2022, Pages 57-64.e3
Comparative Outcomes of Cap Assisted Endoscopic Resection and Endoscopic Submucosal Dissection in Dysplastic Barrett’s Esophagus
D. ChamilCodipilly?aLovekiratDhaliwal?aMeherOberoi?ParthGandhi?Michele L.Johnson?Ramona M.Lansing?W. ScottHarmsen‡Kenneth K.Wang?Prasad G.Iyer?
doi : 10.1016/j.cgh.2020.11.017
Volume 20, Issue 1, January 2022, Pages 65-73.e1
Biologics for Inflammatory Bowel Disease and Their Safety in Pregnancy: A Systematic Review and Meta-analysis
Ole HaagenNielsen?John MarkGubatan‡Carsten BoghJuhl§||Sarah ElizabethStreett‡CynthiaMaxwell¶
doi : 10.1016/j.cgh.2020.09.021
Volume 20, Issue 1, January 2022, Pages 74-87.e3
Vedolizumab or Tumor Necrosis Factor Antagonist Use and Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease With Prior Malignancy: A Retrospective Cohort Study
AmarVedamurthy?NikithaGangasani‡Ashwin N.Ananthakrishnan?
doi : 10.1016/j.cgh.2020.10.007
Volume 20, Issue 1, January 2022, Pages 88-95
Brief Behavioral Therapy and Bupropion for Sleep and Fatigue in Young Adults With Crohn’s Disease: An Exploratory Open Trial Study
Jana G.Hashash?Mitchell R.Knisely‡AnneGermain§KatherynMcAuliff?MeredithStrassburger?AshleyVachon?David G.Binion?MiguelRegueiro||MeredithWallace§EvaSzigethy?§
doi : 10.1016/j.cgh.2020.09.047
Volume 20, Issue 1, January 2022, Pages 96-104
Sleep disturbances and fatigue are common symptoms amongst patients with Crohn’s disease (CD). The aim of this study was to test the feasibility and effects of a pragmatic, stepped-care intervention for the treatment of poor sleep quality and fatigue in adolescents and young adults with CD.
Efficacy and Safety of Continued Treatment With Mirikizumab in a Phase 2 Trial of Patients With Ulcerative Colitis
William J.Sandborn?MarcFerrante‡Bal R.Bhandari§ElinaBerliba?ToshifumiHibi¶Geert R.D’Haens#Jay L.Tuttle??KathrynKrueger??StuartFriedrich??MichaelDurante??VipinArora??April N.Naegeli??JochenSchmitz??Brian G.Feagan‡‡
doi : 10.1016/j.cgh.2020.09.028
Volume 20, Issue 1, January 2022, Pages 105-115.e14
Maintenance of Remission With Tofacitinib Therapy in Patients With Ulcerative Colitis
Jean-FredericColombel?Mark T.Osterman‡Andrew J.Thorpe§LeonardoSalese§Chudy I.Nduaka§HaiyingZhang§NervinLawendy§Gary S.Friedman§DanielQuirk§ChinyuSu§WalterReinisch||
doi : 10.1016/j.cgh.2020.10.004
Volume 20, Issue 1, January 2022, Pages 116-125.e5
Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis
DanaLukin?aDavidFaleck‡aRonghuiXu§aYiranZhang§AaronWeiss?SatimaiAniwan?SiriKadire¶GloriaTran¶MahmoudRahal¶AdamWinters‡ShreyaChablaney‡Jenna L.Koliani-Pace#JosephMeserve§James P.Campbell??GursimranKochhar‡‡MatthewBohm¶SashidharVarma¶MonikaFischer¶BrigidBoland§SiddharthSingh§RobertHirten‡RyanUngaro‡KarenLasch§§EugeniaShmidt??VipulJairath??DavidHudesman¶¶ShannonChang¶¶ArunSwaminath##BoShen‡‡SunandaKane?Edward V.LoftusJr.?Bruce E.Sands‡Jean-FredericColombel‡Corey A.Siegel#William J.Sandborn§Parambir S.Dulai§
doi : 10.1016/j.cgh.2020.10.003
Volume 20, Issue 1, January 2022, Pages 126-135
Comparing Costs and Outcomes of Treatments for Irritable Bowel Syndrome With Diarrhea: Cost-Benefit Analysis
Eric D.Shah?Jessica K.Salwen-Deremer?‡Peter R.Gibson§Jane G.Muir§ShantiEswaran||William D.Chey||
doi : 10.1016/j.cgh.2020.09.043
Volume 20, Issue 1, January 2022, Pages 136-144.e31
Program Components and Results From an Organized Colorectal Cancer Screening Program Using Annual Fecal Immunochemical Testing
KevinSelby?aChristopher D.Jensen‡aTheodore R.Levin§Jeffrey K.Lee‡Joanne E.Schottinger||Wei K.Zhao‡Douglas A.Corley‡Chyke A.Doubeni¶#
doi : 10.1016/j.cgh.2020.09.042
Volume 20, Issue 1, January 2022, Pages 145-152
Pancreatic QST Differentiates Chronic Pancreatitis Patients into Distinct Pain Phenotypes Independent of Psychiatric Comorbidities
MahyaFaghih?Anna E.Phillips‡LouiseKuhlmann§?ElhamAfghani?¶Asbjørn M.Drewes§?DhirajYadav‡Vikesh K.Singh?¶bSøren S.Olesen§?bPancreatic Quantitative Sensory Testing (P-QST) Consortium
doi : 10.1016/j.cgh.2020.10.036
Volume 20, Issue 1, January 2022, Pages 153-161.e2
SARS-CoV2-specific Humoral and T-cell Immune Response After Second Vaccination in Liver Cirrhosis and Transplant Patients
Darius F.Ruether?aGolda M.Schaub?§aPaul M.Duengelhoef‡FriedrichHaag‡Thomas T.Brehm?§AnahitaFathi?§||MalteWehmeyer?JacquelineJahnke-Triankowski#LeonieMayer§||ArminHoffmann¶LutzFischer#Marylyn M.Addo?§||MarcLütgehetmann§¶Ansgar W.Lohse?§JulianSchulze zur Wiesch?¶bMartinaSterneck?b
doi : 10.1016/j.cgh.2021.09.003
Volume 20, Issue 1, January 2022, Pages 162-172.e9
Validation of a Novel Multitarget Blood Test Shows High Sensitivity to Detect Early Stage Hepatocellular Carcinoma
Naga P.Chalasani?KylePorter‡AbhikBhattacharya§Adam J.Book§Brenda M.Neis§Kong M.Xiong§Tiruvidaimarudur S.Ramasubramanian§David K.EdwardsV‡IreneChen‡ScottJohnson‡Lewis R.Roberts||John B.Kisiel||K. RajenderReddy¶Amit G.Singal#Marilyn C.Olson§Janelle J.Bruinsma§
doi : 10.1016/j.cgh.2021.08.010
Volume 20, Issue 1, January 2022, Pages 173-182.e7
Provider Attitudes Toward Risk-Based Hepatocellular Carcinoma Surveillance in Patients With Cirrhosis in the United States
Nicole J.Kim?KarineRozenberg-Ben-Dror‡David A.Jacob§Nicole E.Rich||Amit G.Singal||Elizabeth S.Aby¶Ju DongYang#VeronicaNguyen??AnjanaPillai‡‡MichaelFuchs§§Andrew M.Moon||||HershShroff¶¶Parul D.Agarwal##PonniPerumalswami???ShaunChandna‡‡‡KaliZhou§§§Yuval A.Patel||||||Nyan L.Latt¶¶¶RobertWong###AndresDuarte-Rojo????Christina C.Lindenmeyer‡‡‡‡CatherineFrenette§§§§JinGe||||||||NeilMehta||||||||FrancisYao||||||||Jihane N.Benhammou¶¶¶¶Patricia P.Bloom####MichaelLeise?????Hyun-seokKim‡‡‡‡‡CynthiaLevy§§§§§AbbeyBarnard||||||||||MandanaKhalili||||||||George N.Ioannou?¶¶¶¶¶
doi : 10.1016/j.cgh.2020.09.015
Volume 20, Issue 1, January 2022, Pages 183-193
Depression and Anxiety Are Common Among Patients With Cirrhosis
RubenHernaez?‡§Jennifer R.Kramer‡§||AishaKhan‡§JessicaPhillips¶KatharineMcCallister¶KassieChaffin‡Adriana PortelaHernandez‡HannahFullington¶CynthiaOrtiz¶James-MichaelBlackwell¶AdamLoewen¶YanLiu‡§||Jasmin A.Tiro¶Simon C.Lee¶Amit G.Singal¶#
doi : 10.1016/j.cgh.2020.08.045
Volume 20, Issue 1, January 2022, Pages 194-203.e1
Patient Preferences for Hepatocellular Carcinoma Surveillance Parameters
Sean A.WoolenMD, MS?aAmit G.SingalMD, MS‡§aMatthew S.DavenportMD||¶Jonathan P.TroostPhD#ShokoufehKhalatbariMS#SukulMittal‡SeharSiddiqui??AustinFobarMS??JasonMorris‡‡MobolajiOdewoleBS, MPH‡Elliot B.Tapper??AnjanaPillaiMD§‡‡bNeehar D.ParikhMD§??b
doi : 10.1016/j.cgh.2021.02.024
Volume 20, Issue 1, January 2022, Pages 204-215.e6
A Cost-Effectiveness Analysis for Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Prophylaxis in the United States
Nikhil R.Thiruvengadam?‡§MonicaSaumoy‡YecheskelSchneider||SaraAttala‡JosephTriggs‡PeterLee‡Michael L.Kochman‡§
doi : 10.1016/j.cgh.2021.08.050
Volume 20, Issue 1, January 2022, Pages 216-226.e42
Agreement Between the Prevalence of Nonalcoholic Fatty Liver Disease Determined by Transient Elastography and Fatty Liver Indices
Gieira S.JonesChristian S.AlvarezBarry I.GraubardKatherine A.McGlynn
doi : 10.1016/j.cgh.2020.11.028
Volume 20, Issue 1, January 2022, Pages 227-229.e2
Tenofovir Alafenamide Attenuates Effects of Diabetes and Body Mass on Serum Alanine Aminotransferase Activities in Patients With Chronic Hepatitis B
PimsiriSripongpun?‡W. RayKim?AjithaMannalithara?AllisonKwong?TamiDaugherty?AparnaGoel?Paul Y.Kwo?
doi : 10.1016/j.cgh.2020.11.047
Volume 20, Issue 1, January 2022, Pages 230-232
Cholecystectomy for Biliary Gallstone Pancreatitis Is Often Not Performed During Index Hospitalization and Is Associated With Worse Outcomes
Divyanshoo R.Kohli?MadhavDesai?Kevin F.Kennedy‡SravanthiParasa§PrateekSharma?
doi : 10.1016/j.cgh.2020.12.002
Volume 20, Issue 1, January 2022, Pages 233-235.e1
Early Combined Immunosuppression Reduces Complications in Long-standing Crohn's Disease: A Post Hoc Analysis of REACT
JurijHanzel?‡ChristopherMa‡§GuangyongZou‡||SiddharthSingh¶#Parambir S.Dulai¶Brian G.Feagan‡||??Geert R.D’Haens‡‡‡William J.Sandborn‡¶VipulJairath‡||??
doi : 10.1016/j.cgh.2020.12.019
Volume 20, Issue 1, January 2022, Pages 236-238
Increased Hepatic Expression of SARS-CoV-2 Entry Points and Proinflammatory Cytokines in Cirrhosis
NathalyLimon-De La RosaEduardoCervantes-AlvarezNaluNavarro-Alvarez
doi : 10.1016/j.cgh.2021.08.053
Volume 20, Issue 1, January 2022, Pages 239-241.e3
Exam 1: Comparative Outcomes of Cap Assisted Endoscopic Resection and Endoscopic Submucosal Dissection in Dysplastic Barrett’s Esophagus
doi : 10.1016/j.cgh.2021.10.012
Volume 20, Issue 1, January 2022, Pages e7-e8
Endoscopic Polypectomy: How Should We Determine Complete Resection Status?
RoupenDjinbachianMDDaniel VonRentelnMD
doi : 10.1016/j.cgh.2020.12.006
Volume 20, Issue 1, January 2022, Pages 242-243
Liver Injury After Dietary Supplements in Patients Living With HIV: A Call to Action
DarioCattaneoPhDAndreaGiacomelliMDCristinaGervasoniMD
doi : 10.1016/j.cgh.2021.02.031
Volume 20, Issue 1, January 2022, Pages 243-244
No Convincing Evidence to Support a Bimodal Age of Onset in Idiopathic Chronic Pancreatitis
Jian-MinChenMD, PHDDavid N.CooperPHDClaudeFérecMD, PHD
doi : 10.1016/j.cgh.2021.01.049
Volume 20, Issue 1, January 2022, Pages 244-245
Stoma Formation and Antidepressant Use in Patients With Crohn's Disease
TomoyukiKawadaMD
doi : 10.1016/j.cgh.2021.02.018
Volume 20, Issue 1, January 2022, Pages 245-246
DAA Therapy in Hepatitis C in Patients With Chronic Kidney Disease: New Information for GFR Category G4 and G5
Chia-YenDaiMD, PhDJee-FuHuangMD, PhDWan-LongChuangMD, PhDMing-LungYuMD, PhD
doi : 10.1016/j.cgh.2020.10.023
Volume 20, Issue 1, January 2022, Pages 246-247
Reply
Ahmed A.AwanMDMichelJadoulMDPaulMartinMD
doi : 10.1016/j.cgh.2021.03.033
Volume 20, Issue 1, January 2022, Page 247
COVID-19 Mortality: The Culprit May Not Be Proton Pump Inhibitors
ZhihuiDuanMMShengyunZhouMBXiaofangSunMB
doi : 10.1016/j.cgh.2021.08.013
Volume 20, Issue 1, January 2022, Pages 247-248
Reply
Simone BastrupIsraelsenMDJesperHallasMD, DMScThomasBenfieldMD, DMSc
doi : 10.1016/j.cgh.2021.09.016
Volume 20, Issue 1, January 2022, Pages 248-249
